Hypothyroidism / Subclinical Hypothyroidism

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated July 27, 2026

Hypothyroidism is a condition of insufficient thyroid hormone production, most commonly caused by autoimmune Hashimoto's thyroiditis in iodine-sufficient regions. Overt hypothyroidism is diagnosed by elevated TSH with low free T4. Subclinical hypothyroidism is the milder form: TSH is elevated while free T4 remains within the normal range. Both conditions affect reproductive function. Subclinical hypothyroidism is associated with ovulatory dysfunction, impaired implantation, and increased miscarriage risk even when symptoms are absent.¹

Thyroid autoantibodies compound the risk independently of TSH. A meta-analysis found that euthyroid women with thyroid peroxidase antibodies (TPO-Ab) had significantly higher rates of miscarriage and preterm birth compared to antibody-negative women.² This matters clinically: a woman with normal TSH but elevated TPO-Ab is not in the clear. Antibody status is part of a complete TSH screening picture.

RRM screens thyroid function and antibody status in all infertility and recurrent pregnancy loss evaluations. The clinical threshold for intervention is typically set lower than conventional population norms. The observational evidence above explains why. Subclinical hypothyroidism and thyroid antibody positivity both track with higher rates of ovulatory dysfunction, impaired implantation, and pregnancy loss. That holds even when TSH falls within a standard reference range. A Cochrane review looked at thyroxine replacement in subfertile women with subclinical hypothyroidism or autoimmune thyroid disease. It found the randomized-trial evidence low certainty and insufficient to settle treatment questions.³ That gap in trial-quality evidence still leaves the observational picture intact. Treatment decisions in this population rest on individual clinical judgment: a woman's labs and history, not a single blanket protocol.

Untreated hypothyroidism also affects the luteal phase. Thyroid hormone is necessary for normal progesterone production and corpus luteum function. Women presenting with luteal phase deficiency or recurrent early pregnancy loss warrant thyroid evaluation before any hormonal support protocol is initiated. Treating the thyroid first, when indicated, corrects the upstream deficiency rather than compensating for it downstream.

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.